Q Fever Market - Top Companies and Manufacturers

  • Report ID: 4118
  • Published Date: Aug 13, 2024
  • Report Format: PDF, PPT

Companies Dominating the Q Fever Landscape

    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Sanofi aventis Groupe
    • Arix Bioscience plc
    • Yashica Pharmaceuticals Pvt. Ltd
    • Basilea Pharmaceutica Ltd.
    • Merck KGaA
    • Melinta Therapeutics LLC
    • Teva Pharmaceutical Ltd.
    • Bayer AG
    • Johnson & Johnson Services, Inc.

Browse Key Market Insights with Data Illustration:

In the News

 

  • In 2022, Pfizer Inc. and Myovant Science provided an update on MYFEMBREE, a 1 mg medication designed for severe pain management, revealing that the U.S. FDA has extended its review timeline for the drug.
  • In 2022, Sanofi introduced Foundation S, an initiative dedicated to fostering a healthy and beneficial future for both present and future generations.

Author Credits:  Radhika Pawar


  • Report ID: 4118
  • Published Date: Aug 13, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of Q fever is assessed at USD 548.92 million.

Q Fever Market size was valued at USD 527.4 million in 2023 and is likely to reach USD 1 billion by 2036, registering around 5.1% CAGR during the forecast period i.e., between 2024-2036. Growing patient pool on account of the higher prevalence of Q fever, rising demand for enhanced diagnostic solutions, and increasing awareness of acute & chronic Q fever prevention will propel the market growth.

North America industry is estimated to account for largest revenue share by 2036, due to increasing awareness of infectious diseases, growing demand for enhanced diagnostic facilities, and a higher prevalence of Q fever in the region.

The major players in the market are Pfizer Inc., Arix Bioscience plc, Yashica Pharmaceuticals Pvt. Ltd, Merck KGaA, Melinta Therapeutics LLC, Teva Pharmaceutical Ltd., Bayer AG, and Johnson & Johnson Services, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample